iLet Bionic Pancreas (BBNX) Enterprise Value to EBITDA Ratio
Beta Bionics Inc is integrating AI technologies into its bionic pancreas, while the active rollout of the iLet system is driving current growth. The levered EV/EBITDA ratio demonstrates debt sustainability, with the 0.00 mark indicating the level of market valuation. However, geopolitical instability and supply chain disruptions create risks for patent protection and component deliveries.
Comprehensive metric breakdowns and analytics for betabionics.com (BBNX)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
BBNX - Net Financial Result|Projected Future Earnings Beta Bionics Inc|BBNX - Price to Earnings Ratio|Forward P/E Multiple Beta Bionics Inc|BBNX - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization iLet Bionic Pancreas|BBNX - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Beta Bionics|BBNX - Earnings per share for the trailing year|Quarterly EPS earnings growth betabionics.com|BBNX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Beta Bionics Inc
Analysis of all company metrics:Beta Bionics Corp BBNX
To minimize fundamental risks, investors should select assets where Enterprise Value (EV) is measured against Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). The EV/EBITDA multiple for Beta Bionics Inc (BBNX) reflects the actual value of the enterprise inclusive of debt, which is critical for Beta Bionics Inc (BBNX) when hiring high-cost medical engineers. This chart's price action reflects how effectively the startup's scientific potential is converted into capitalization.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|IRMD: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation EMBC|TNDM (Tandem Diabetes Care, Inc.) - EV/EBITDA Multiple|AxoGen Inc (AXGN) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple SIBN|Enterprise Value to EBITDA Ratio Orthofix Corp OFIX|EV/EBITDA Multiple BVS (Bioventus Inc.)|EV/EBITDA Multiple OrthoPediatrics Corp KIDS|TMCI - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CARL (Carlsmed Corp) - Enterprise Value to EBITDA Ratio|RxSight Ophthalmic - Business Value to Operating Income Before Depreciation|CLPT (ClearPoint Neuro Inc.) - EV/EBITDA Multiple|Company Value to EBITDA stereotaxis.com STXS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Enterprise Value to EBITDA Multiple|Orchestra BioMed - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|LFWD: EV/EBITDA Multiple|AMIX (Autonomix Medical) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|IVF (INVO Fertility) - EV/EBITDA Multiple|Company Value to EBITDA Bone Biologics Corp. BBLG|Enterprise Value to EBITDA Ratio AXNX (Axonics Modulation Technologies)|Enterprise Value to Operating Income Before Depreciation Ratio BIOL|EV/EBITDA Multiple DYNT (Dynatronics)|EV/EBITDA Multiple Paragon 28 Inc. FNA|INVO: Enterprise Value to EBITDA Ratio
